197 related articles for article (PubMed ID: 18375356)
1. The implications of colorectal cancer molecular biology in clinical practice.
Kargozaran H; Kahlenberg M; Khatri VP
Surg Oncol Clin N Am; 2008 Apr; 17(2):341-55, viii-ix. PubMed ID: 18375356
[TBL] [Abstract][Full Text] [Related]
2. [Current concepts in the genetics of hereditary and sporadic colorectal cancer and the role of genetics in clinical practice: sporadic and IBD-associated colorectal tumors, significance of genetic tests in diagnosis, prognosis and assessment of chemotherapy outcome].
Lakatos PL; Lakatos L
Orv Hetil; 2006 Mar; 147(10):449-55. PubMed ID: 16573174
[TBL] [Abstract][Full Text] [Related]
3. Molecular biology of colorectal cancer: new targets.
Kitisin K; Mishra L
Semin Oncol; 2006 Dec; 33(6 Suppl 11):S14-23. PubMed ID: 17178280
[TBL] [Abstract][Full Text] [Related]
4. Molecular pathogenesis of colorectal cancer: implications for molecular diagnosis.
Arnold CN; Goel A; Blum HE; Boland CR
Cancer; 2005 Nov; 104(10):2035-47. PubMed ID: 16206296
[TBL] [Abstract][Full Text] [Related]
5. Review article: the chemoprevention of colorectal carcinoma.
Gasche C
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():31-5. PubMed ID: 15352891
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in epidemiological, clinical and pathological characteristics of colorectal cancer.
Koo JH; Leong RW
J Gastroenterol Hepatol; 2010 Jan; 25(1):33-42. PubMed ID: 19874446
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in colorectal cancer genetics and diagnostics.
Cheah PY
Crit Rev Oncol Hematol; 2009 Jan; 69(1):45-55. PubMed ID: 18774731
[TBL] [Abstract][Full Text] [Related]
8. The molecular biology of colorectal cancer development and the associated genetic events.
Navaratnam RM; Chowaniec J; Winslet MC
Ann R Coll Surg Engl; 1999 Sep; 81(5):312-9. PubMed ID: 10645173
[TBL] [Abstract][Full Text] [Related]
9. The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers.
Kodach LL; Wiercinska E; de Miranda NF; Bleuming SA; Musler AR; Peppelenbosch MP; Dekker E; van den Brink GR; van Noesel CJ; Morreau H; Hommes DW; Ten Dijke P; Offerhaus GJ; Hardwick JC
Gastroenterology; 2008 May; 134(5):1332-41. PubMed ID: 18471510
[TBL] [Abstract][Full Text] [Related]
10. Molecular testing in colorectal cancer: diagnosis of Lynch syndrome and personalized cancer medicine.
Shi C; Washington K
Am J Clin Pathol; 2012 Jun; 137(6):847-59. PubMed ID: 22586043
[TBL] [Abstract][Full Text] [Related]
11. Common and distinct genomic events in sporadic colorectal cancer and diverse cancer types.
Martin ES; Tonon G; Sinha R; Xiao Y; Feng B; Kimmelman AC; Protopopov A; Ivanova E; Brennan C; Montgomery K; Kucherlapati R; Bailey G; Redston M; Chin L; DePinho RA
Cancer Res; 2007 Nov; 67(22):10736-43. PubMed ID: 18006816
[TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
[TBL] [Abstract][Full Text] [Related]
13. Molecular markers in prognosis of colorectal cancer and prediction of response to treatment.
Pasche B; Mulcahy M; Benson AB
Best Pract Res Clin Gastroenterol; 2002 Apr; 16(2):331-45. PubMed ID: 11969242
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
[TBL] [Abstract][Full Text] [Related]
15. [Familial colorectal cancer type X: clinical, pathological and molecular characterization].
Ferreira S; Lage P; Sousa R; Claro I; Francisco I; Filipe B; Suspiro A; Chaves P; Rodrigues P; Albuquerque C; Nobre Leitão C
Acta Med Port; 2009; 22(3):207-14. PubMed ID: 19686620
[TBL] [Abstract][Full Text] [Related]
16. Familial colorectal cancer, can it be identified by microsatellite instability and chromosomal instability? - A case-control study.
Sunde L; Bisgaard ML; Soll-Johanning H; Jacobsen NO; Bolund L; Skouv J; Lynge E
Cancer Biomark; 2009; 5(4):197-205. PubMed ID: 19729829
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of genetic variations in the VEGF system in relation to colorectal cancer.
Hansen TF; Jakobsen A
Pharmacogenomics; 2011 Dec; 12(12):1681-93. PubMed ID: 22118052
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis and colorectal cancer: implications for therapy.
Yang SY; Sales KM; Fuller B; Seifalian AM; Winslet MC
Trends Mol Med; 2009 May; 15(5):225-33. PubMed ID: 19362056
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics and -genetics in colorectal cancer.
Pohl A; Lurje G; Manegold PC; Lenz HJ
Adv Drug Deliv Rev; 2009 May; 61(5):375-80. PubMed ID: 19100300
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the biology of colorectal cancer.
Grogan L; Behan KA; Johnston PG
Histol Histopathol; 1996 Jul; 11(3):807-20. PubMed ID: 8839768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
